Core Scientific Reports Second-Quarter 2026 Results with Digital Asset Mining and Colocation Services Revenue Breakdown

Business Model and Operational Segments

Core Scientific operates within the digital asset infrastructure sector, providing essential computing services to cryptocurrency miners and blockchain participants. The company's business is organized into three distinct revenue-generating segments that serve different customer needs and market opportunities. Each segment reflects Core Scientific's diverse approach to capturing value from the expanding digital asset ecosystem.

The colocation services segment provides physical space and infrastructure within Core Scientific's data centers for customers who bring their own mining equipment. Digital asset self-mining services represent operations where Core Scientific owns and operates mining hardware directly, generating revenue from the digital assets produced. The digital asset hosted mining service segment offers customers the ability to deploy mining equipment at Core Scientific facilities with the company managing operational aspects. This tiered service approach allows Core Scientific to serve both enterprise customers and smaller operators seeking turnkey solutions.

Geographic Footprint and Physical Infrastructure

Core Scientific's operational facilities are distributed across multiple states, demonstrating geographic diversification in its data center infrastructure portfolio. As of June 30, 2026, the company disclosed properties and operations spanning Alabama, Georgia, Kentucky, North Carolina, North Dakota, Oklahoma, and Texas. Texas serves as the company's state of incorporation and operational headquarters, reflecting the region's emergence as a significant hub for digital asset infrastructure development. The geographic spread reduces concentration risk associated with regional power costs, grid reliability, and regulatory environments.

The company's property portfolio includes land and land improvements, building and building improvements, mining equipment, and electrical and mechanical equipment. The filing indicates Core Scientific maintains both depreciable property, plant and equipment assets and construction in progress, suggesting ongoing facility expansion and equipment deployment initiatives. The company's infrastructure investments are substantial, reflecting the capital-intensive nature of operating large-scale data centers designed for continuous cryptocurrency mining operations and customer colocation services.

Debt Structure and Capital Obligations

Core Scientific maintains a diversified debt structure comprising senior secured notes, convertible senior notes, and other secured credit facilities. The company disclosed senior secured notes due 2031 as of June 30, 2026, representing a significant long-term obligation in its capital structure. Additionally, the company carries convertible senior notes with 2029 and 2031 maturity dates, providing lenders with conversion rights into Core Scientific common stock under specified conditions. These instruments reflect the company's reliance on debt financing to fund equipment acquisition, facility development, and operational expansion.

The filing references a term loan facility as of March 31, 2026, indicating Core Scientific utilizes secured credit arrangements in addition to its note offerings. The varied maturity dates of debt instruments create a staggered repayment schedule, potentially reducing refinancing risk concentration in any single period. The presence of both senior and convertible debt suggests the company has attracted institutional investors willing to accept structured returns and equity participation opportunities. The capital structure reflects Core Scientific's significant infrastructure investments required to maintain competitive computational capacity in the dynamic digital asset mining industry.

Asset Acquisitions and Technology Rights

Core Scientific completed an acquisition on May 5, 2026, referred to in the filing as the Hunt County Acquisition, which involved developed technology rights and related infrastructure assets. This transaction represents the company's strategy to expand operational capacity and acquire proven computing technology used in digital asset mining operations. The timing of this mid-year acquisition suggests strategic opportunities emerged to strengthen Core Scientific's competitive positioning within its addressable market. The filing indicates the acquired assets generated transaction activity between May 5 and May 6, 2026, consistent with deal closing and integration processes.

The developed technology rights acquired through the Hunt County transaction represent intellectual property and operational methodologies that enhance Core Scientific's mining efficiency and computing infrastructure capabilities. By acquiring established technology frameworks, the company accelerates deployment timelines and reduces the need to develop competing solutions independently. The integration of these assets into Core Scientific's existing operations provides opportunities to leverage technology across multiple facilities and customer engagements. The acquisition underscores management's confidence in the company's ability to deploy capital effectively and generate returns from infrastructure consolidation.

Bitcoin Holdings and Digital Asset Management

Core Scientific disclosed Bitcoin holdings as of June 30, 2026, reflecting the company's strategy to retain certain digital assets produced through its self-mining operations. The inclusion of Bitcoin on the company's balance sheet indicates management's decision to hold cryptocurrencies as corporate assets rather than immediately liquidating mining output. Bitcoin valuation fluctuates based on market conditions, creating both upside appreciation potential and downside valuation risk for shareholders. The filing documents Bitcoin holdings separately from other assets, enabling investors to assess the company's exposure to cryptocurrency price movements.

The treatment of Bitcoin as a company asset differentiates Core Scientific from purely service-based mining operators who immediately convert digital assets to fiat currency. By maintaining Bitcoin positions, Core Scientific participates in potential appreciation while also bearing the volatility associated with cryptocurrency prices. The balance sheet presentation of Bitcoin holdings as of December 31, 2025, and June 30, 2026, allows investors to compare valuation changes across reporting periods. This approach aligns Core Scientific's financial performance with broader digital asset market conditions, creating dual leverage to both mining profitability and Bitcoin price appreciation.

Revenue Recognition and Operating Expenses

The filing discloses detailed cost of revenue information broken down by business segment for both quarterly and year-to-date periods ending June 30 in 2026 and 2025. Cost of revenue for colocation services, digital asset self-mining services, and digital asset hosted mining services are presented separately, enabling investors to analyze gross margin performance by segment. The comparative presentation of first and second quarter periods, as well as year-to-date figures, provides visibility into seasonal patterns and operational efficiency trends across the business. Selling, general, and administrative expenses are also disclosed for comparable periods, allowing assessment of operating leverage and corporate overhead management.

The segmented presentation of costs allows investors to identify which service categories generate the strongest margins and contribute most meaningfully to company profitability. Colocation services typically carry lower cost structures relative to self-mining operations due to customer assumption of equipment risks and responsibility. Hosting services balance the revenue potential of self-mining with customer-provided computing capacity, offering operational flexibility. The comparison of 2026 results to 2025 comparable periods reveals growth trajectories and cost inflation pressures. Investors monitoring Core Scientific's operational efficiency should focus on trends in cost of revenue as a percentage of segment revenue and changes in selling, general, and administrative expenses relative to total revenue.

Warrant Instruments and Equity Dilution Considerations

Core Scientific has issued warrant instruments that provide holders with rights to purchase additional shares of company common stock at specified exercise prices. The filing discloses two warrant tranches with different exercise price provisions, including warrants with an exercise price of $6.81 per share and warrants with an exercise price of $0.01 per share. The presence of deep in-the-money warrants at $0.01 exercise price creates substantial potential dilution if warrant holders exercise conversion rights. These instruments were issued as components of financing transactions on January 23, 2024, reflecting capital raising activities completed more than two years prior to the reporting period.

The warrant instruments represent a significant source of potential equity dilution for existing shareholders, as exercise of the $0.01 warrants would generate substantial proceeds for the company but substantially increase outstanding share count. The filing provides warrant activity data for the six-month and year-to-date periods ending June 30, 2026, documenting holdings as of specific reporting dates. Investors evaluating Core Scientific's capital structure and dilution risk should closely monitor warrant exercise activity and the company's ability to manage outstanding equity instruments effectively. The terms and potential exercise patterns of these warrants could materially affect earnings per share calculations and future capital raising flexibility.

Fair Value Measurement and Financial Reporting Standards

Core Scientific applies fair value measurement standards to certain balance sheet items, with the filing indicating use of money market funds and fair value inputs classified as Level 1 measurements. Level 1 fair value inputs derive from quoted prices in active markets for identical assets, providing the highest level of reliability in valuation methodology. The company's cash equivalents and highly liquid investments are measured using observable market prices, reducing estimation and valuation uncertainty. The disclosure of fair value measurement hierarchy levels demonstrates compliance with U.S. Generally Accepted Accounting Principles and provides transparency regarding the reliability of asset valuations presented in the financial statements.

The treatment of cash and short-term investments using Level 1 fair value inputs indicates Core Scientific maintains conservative liquidity management practices with readily valued assets. This approach contrasts with companies that hold significant positions in illiquid or specialty investments requiring complex valuation methodologies. Investors evaluating Core Scientific's balance sheet strength can have confidence that reported cash and cash equivalent positions accurately reflect true economic value. The transparent presentation of fair value measurement methodologies supports investor confidence in the reliability of reported financial position and enables accurate comparison to peer companies.

Quarter-Over-Quarter Operational Performance Assessment

The filing presents both quarterly and year-to-date revenue and expense data for the six-month periods ended June 30, 2026, and June 30, 2025, enabling direct comparison of operational performance across comparable timeframes. Second quarter revenue and expenses for each business segment in 2026 can be compared directly to second quarter 2025 results, isolating the impact of seasonal factors and identifying meaningful year-over-year trends. Year-to-date results through June 30 eliminate seasonal distortions and reflect six-month operational trajectories for both fiscal years. The dual presentation of quarterly and cumulative data provides investors with multiple analytical perspectives on company performance and operational momentum.

Investors analyzing Core Scientific's performance trajectory should examine whether revenue growth accelerated during the 2026 periods compared to 2025, reflecting capacity additions and market demand expansion. Cost trends across segments reveal whether the company achieved operational efficiencies through technology optimization, facility utilization improvements, or procurement advantages. The year-to-date expense management relative to revenue generation indicates whether operating leverage is expanding or contracting across the business. Management's ability to grow revenue while controlling selling, general, and administrative expenses demonstrates operational discipline and capital efficiency during periods of business expansion.

Equipment Valuation and Depreciation Impacts

Core Scientific's balance sheet reflects substantial investments in mining equipment and electrical and mechanical equipment deployed across its facilities. The filing provides valuation ranges for building and building improvements as of June 30, 2026, with both minimum and maximum values disclosed. Mining equipment represents a significant asset category subject to rapid technological obsolescence as the industry develops more efficient computing hardware. The depreciation of equipment across the six-month period ending June 30, 2026, compared to prior periods reflects both usage wear and the impact of new equipment acquisitions. The filing documents depreciation expense related to depreciable property, plant and equipment and mining infrastructure, enabling investors to assess the productive asset base supporting revenue generation.

The valuation of mining equipment requires careful consideration of technological advancement rates, equipment lifespan assumptions, and salvage value expectations. As newer, more efficient mining hardware becomes available, older equipment may experience accelerated depreciation or obsolescence charges. The company's ability to refresh equipment strategically while maintaining operational capacity affects overall profitability and competitive positioning. Construction in progress represents equipment and facilities still being installed and not yet generating revenue, indicating Core Scientific is actively expanding its operational infrastructure. Investors should monitor the conversion of construction in progress to productive assets and assess whether capital deployment decisions are generating expected returns.